SLC2A1 and gastric cancer: Some studies indicated that there was a poor prognostic value of GLUT1 in oral squamous cell carcinoma [27], malignant salivary gland tumors [24], colorectal cancer [18, 19], gastric cancer [16, 17], gallbladder cancer [10, 15], extrahepatic bile duct cancer [10], adrenocortical carcinoma [25] and neuroblastic tumor [28].